# Efficacy of tACS for Treatment of Auditory Hallucinations in Refractory Schizophrenia

> **NCT05282329** · NA · COMPLETED · sponsor: **Tianjin Anding Hospital** · enrollment: 50 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DEVICE:** Transcranial alternating Current Stimulation (tACS)-active
- **DEVICE:** Transcranial Alternating Current Stimulation (tACS)-sham

## Key facts

- **NCT ID:** NCT05282329
- **Lead sponsor:** Tianjin Anding Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-01
- **Primary completion:** 2022-08-31
- **Final completion:** 2022-09-21
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2022-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05282329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05282329, "Efficacy of tACS for Treatment of Auditory Hallucinations in Refractory Schizophrenia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05282329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*